Immunic, Inc.
IMUX· Nasdaq
IMUXImmunic, Inc.
Filed May 8, 2020 · 10-Q · 38 days after period end · 0001280776-20-000015
| Metric | Q1 2020 | Q1 2019 | Q1 2018 | Q1 2017 |
|---|---|---|---|---|
| Net Income | -$8.49M | -$4.31M | -$2.26M | -$12.60M |
| EPS Diluted | -$0.79 | -$5.09 | -$2.67 | -$0.39 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Immunic, Inc. · CIK 1280776 · Engraved from SEC EDGAR
ended Mar 31, 2020 · filed May 8, 2020 · 38 d after period end
